These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2196169)

  • 1. Ketamine, phencyclidine, and MK-801 protect against kainic acid-induced seizure-related brain damage.
    Clifford DB; Olney JW; Benz AM; Fuller TA; Zorumski CF
    Epilepsia; 1990; 31(4):382-90. PubMed ID: 2196169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketamine and MK-801 prevent degeneration of thalamic neurons induced by focal cortical seizures.
    Clifford DB; Zorumski CF; Olney JW
    Exp Neurol; 1989 Sep; 105(3):272-9. PubMed ID: 2670599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.
    Tricklebank MD; Singh L; Oles RJ; Preston C; Iversen SD
    Eur J Pharmacol; 1989 Aug; 167(1):127-35. PubMed ID: 2550253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effects of MK-801 in vivo: selectivity and evidence for delayed degeneration mediated by NMDA receptor activation.
    Foster AC; Gill R; Woodruff GN
    J Neurosci; 1988 Dec; 8(12):4745-54. PubMed ID: 2904493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of anticonvulsant effect of ethanol against NMDA-, kainic acid- and picrotoxin-induced convulsions in rats.
    Kulkarni SK; Mehta AK; Ticku MK
    Life Sci; 1990; 46(7):481-7. PubMed ID: 2406529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncompetitive N-methyl-D-aspartate antagonists affect multiple ionic currents.
    Rothman S
    J Pharmacol Exp Ther; 1988 Jul; 246(1):137-42. PubMed ID: 2455788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a role of the N-methyl-D-aspartate (NMDA) receptor in cortical spreading depression in the rat.
    Marrannes R; Willems R; De Prins E; Wauquier A
    Brain Res; 1988 Aug; 457(2):226-40. PubMed ID: 2851364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The noncompetitive N-methyl-D-aspartate antagonists, MK-801, phencyclidine and ketamine, increase the potency of general anesthetics.
    Daniell LC
    Pharmacol Biochem Behav; 1990 May; 36(1):111-5. PubMed ID: 2190239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.
    Koek W; Woods JH; Winger GD
    J Pharmacol Exp Ther; 1988 Jun; 245(3):969-74. PubMed ID: 2838610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-methyl-D-aspartate antagonism and phencyclidine-like activity: a drug discrimination analysis.
    Koek W; Woods JH; Colpaert FC
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1017-25. PubMed ID: 2193142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dextromethorphan inhibits NMDA-induced convulsions.
    Ferkany JW; Borosky SA; Clissold DB; Pontecorvo MJ
    Eur J Pharmacol; 1988 Jun; 151(1):151-4. PubMed ID: 3046955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMDA antagonists differentiate epileptogenesis from seizure expression in an in vitro model.
    Stasheff SF; Anderson WW; Clark S; Wilson WA
    Science; 1989 Aug; 245(4918):648-51. PubMed ID: 2569762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MK-801 powerfully protects against N-methyl aspartate neurotoxicity.
    Olney J; Price M; Salles KS; Labruyere J; Frierdich G
    Eur J Pharmacol; 1987 Sep; 141(3):357-61. PubMed ID: 3311770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist.
    Wong EH; Kemp JA; Priestley T; Knight AR; Woodruff GN; Iversen LL
    Proc Natl Acad Sci U S A; 1986 Sep; 83(18):7104-8. PubMed ID: 3529096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of [3H]norepinephrine from rat hippocampal slices by N-methyl-D-aspartate: comparison of the inhibitory effects of Mg2+ and MK-801.
    Schmidt CJ; Taylor VL
    Eur J Pharmacol; 1988 Oct; 156(1):111-20. PubMed ID: 2850205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMDA receptor antagonists and limbic status epilepticus: a comparison with standard anticonvulsants.
    Bertram EH; Lothman EW
    Epilepsy Res; 1990 Apr; 5(3):177-84. PubMed ID: 2166658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of anticonvulsant treatment on kainic acid-induced increases in peptide levels.
    Marksteiner J; Prommegger R; Sperk G
    Eur J Pharmacol; 1990 Jun; 181(3):241-6. PubMed ID: 1974515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticonvulsant actions of MK-801 on the lithium-pilocarpine model of status epilepticus in rats.
    Ormandy GC; Jope RS; Snead OC
    Exp Neurol; 1989 Nov; 106(2):172-80. PubMed ID: 2553470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic administration of MK-801 prevents N-methyl-D-aspartate-induced neuronal degeneration in rat brain.
    Foster AC; Gill R; Kemp JA; Woodruff GN
    Neurosci Lett; 1987 May; 76(3):307-11. PubMed ID: 3295603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of MK-801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward.
    Herberg LJ; Rose IC
    Psychopharmacology (Berl); 1989; 99(1):87-90. PubMed ID: 2550989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.